Skip to main content
Clinical Trials/NCT04491214
NCT04491214
Completed
N/A

Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)

University Hospital, Strasbourg, France1 site in 1 country112 target enrollmentJuly 24, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Covid19
Sponsor
University Hospital, Strasbourg, France
Enrollment
112
Locations
1
Primary Endpoint
assess quality of life after severe COVID infection
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,...). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization.

Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a "platform" within several physicians (neurologist, biologist, pneumologist...) will be able to follow up patients and perform complementary investigations according to patients injuries.

Registry
clinicaltrials.gov
Start Date
July 24, 2020
End Date
January 21, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

assess quality of life after severe COVID infection

Time Frame: measured at 3 months after ICU left.

assess different dimensions of quality of life: physical and mentaland social dimensions

Secondary Outcomes

  • Quality of life and Clinical status(measured at 3 and 6 months after ICU left.)

Study Sites (1)

Loading locations...

Similar Trials